Mississauga, ON -- (SBWIRE) -- 04/09/2015 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "More Strides Made in Protecting Against Ebola Virus."
Companies mentioned in this article include Inovio Pharmaceuticals (NASDAQ:INO), Cepheid (NASDAQ:CPHD) and Aethlon Medical (OTCQB:AEMD).
Months after estimating that the Ebola outbreak in the West African countries of Sierra Leone, Guinea and Liberia could exceed one million patients at the blistering pace it was going, the scare has been dramatically reduced and the worst-ever Ebola outbreak involves far less risk. The latest data from the World Health Organization (updated April 8, 2015) shows there have been 25,516 Ebola cases reported in the three countries, including 10,573 deaths.
In light of the extremely high mortality rate, the outbreak certainly created awareness of the need for new drugs to treat Ebola. Notably, Profectus BioSciences, a private company specializing in vaccines made from vesicular stomatitis virus, was featured this week in Nature for its single-dose VesiculoVax vaccine that protected macaques from a lethal dose of the Mokona strain of Ebola that is responsible for the West African outbreak.
Elsewhere, Inovio Pharmaceuticals (NASDAQ:INO) said on Wednesday that it has been selected to receive a grant from the Defense Advanced Research Projects Agency, or DARPA, to lead a collaborative team in a $45-million program to develop multiple treatment and prevention approaches against Ebola. In the diagnostics space, Cepheid 's (NASDAQ:CPHD) Xpert Ebola Assay was recently granted the Emergency Use Authorization by the FDA to detect the presence of Ebola Zaire Virus in a person's blood.
Aethlon Medical (OTCQB:AEMD), which we discussed in an article last September for its efforts against the dengue virus, said on Thursday that it has filed a Humanitarian Use Device (HUD) submission to the FDA to support potential market clearance of the Aethlon Hemopurifier as a treatment for Ebola virus. According to the FDA website, an HUD is a device that is intended to benefit patients by treating or diagnosing a disease or condition that affects or is manifested in fewer than 4,000 individuals in the United States per year.
The full version of this article can be found at:
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.